Bernice Kuca

988 total citations
10 papers, 523 citations indexed

About

Bernice Kuca is a scholar working on Surgery, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Bernice Kuca has authored 10 papers receiving a total of 523 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Surgery, 2 papers in Pathology and Forensic Medicine and 2 papers in Oncology. Recurrent topics in Bernice Kuca's work include Migraine and Headache Studies (2 papers), Sports Performance and Training (2 papers) and Cardiovascular Syncope and Autonomic Disorders (2 papers). Bernice Kuca is often cited by papers focused on Migraine and Headache Studies (2 papers), Sports Performance and Training (2 papers) and Cardiovascular Syncope and Autonomic Disorders (2 papers). Bernice Kuca collaborates with scholars based in United States, Slovakia and Brazil. Bernice Kuca's co-authors include Linda Wietecha, Sheena K. Aurora, Peter J. Goadsby, Michael Case, Ellen B. Dennehy, Charly Gaul, Marc B. Garnick, Michael S. Gordon, Kathleen J. Beach and John W. Smith and has published in prestigious journals such as Brain, Neurology and Journal of Applied Physiology.

In The Last Decade

Bernice Kuca

9 papers receiving 502 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bernice Kuca United States 8 196 139 137 135 66 10 523
Mahir Uğur Türkiye 16 70 0.4× 68 0.5× 76 0.6× 165 1.2× 43 0.7× 37 688
Ioannis Papadopoulos Greece 12 62 0.3× 40 0.3× 60 0.4× 96 0.7× 15 0.2× 25 502
C. J. Vecht Netherlands 8 174 0.9× 33 0.2× 45 0.3× 56 0.4× 190 2.9× 17 613
M. Nissilä Finland 18 224 1.1× 112 0.8× 94 0.7× 99 0.7× 33 0.5× 50 899
M. Falqués Spain 9 179 0.9× 148 1.1× 194 1.4× 18 0.1× 32 0.5× 12 595
Frederick J. Derosier United States 12 253 1.3× 433 3.1× 137 1.0× 25 0.2× 82 1.2× 15 692
Mihaela Mates Israel 11 44 0.2× 31 0.2× 67 0.5× 44 0.3× 13 0.2× 16 764
Sandrine Malochet‐Guinamand France 11 104 0.5× 47 0.3× 95 0.7× 84 0.6× 29 0.4× 25 520
Hang Zhang China 13 25 0.1× 63 0.5× 69 0.5× 45 0.3× 55 0.8× 63 517
H. Er Türkiye 13 28 0.1× 36 0.3× 78 0.6× 64 0.5× 27 0.4× 18 840

Countries citing papers authored by Bernice Kuca

Since Specialization
Citations

This map shows the geographic impact of Bernice Kuca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernice Kuca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernice Kuca more than expected).

Fields of papers citing papers by Bernice Kuca

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernice Kuca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernice Kuca. The network helps show where Bernice Kuca may publish in the future.

Co-authorship network of co-authors of Bernice Kuca

This figure shows the co-authorship network connecting the top 25 collaborators of Bernice Kuca. A scholar is included among the top collaborators of Bernice Kuca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernice Kuca. Bernice Kuca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Goadsby, Peter J., Linda Wietecha, Ellen B. Dennehy, et al.. (2019). Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migraine. Brain. 142(7). 1894–1904. 188 indexed citations
2.
Wietecha, Linda, Bernice Kuca, Josephine Asafu‐Adjei, & Sheena K. Aurora. (2018). Phase 3 Studies (SAMURAI, SPARTAN) of Lasmiditan Compared to Placebo for Acute Treatment of Migraine (S50.008). Neurology. 90(15_supplement). 13 indexed citations
4.
Pietropaolo, Keith, J. Sullivan-Bolyai, Bernice Kuca, et al.. (2009). 966 IDX184, A LIVER-TARGETED NUCLEOTIDE HCV POLYMERASE INHIBITOR: RESULTS OF A FIRST-IN-MAN SAFETY AND PHARMACOKINETIC STUDY. Journal of Hepatology. 50. S351–S351. 10 indexed citations
5.
Garnick, Marc B., Marilyn Campion, Bernice Kuca, & Kevin M. Tomera. (1999). PSA KINETICS. The Journal of Urology. 98–98.
6.
Garnick, Marc B., Kevin M. Tomera, Marilyn Campion, & Bernice Kuca. (1999). ABARELIX-DEPOT (A-D), A SUSTAINED-RELEASE (SR) FORMULATION OF A POTENT GnRH PURE ANTAGONIST IN PATIENTS (pts) WITH PROSTATE CANCER (PrCA). The Journal of Urology. 340–340. 9 indexed citations
8.
Tepler, Isidore, Laurence Elias, John W. Smith, et al.. (1996). A randomized placebo-controlled trial of recombinant human interleukin-11 in cancer patients with severe thrombocytopenia due to chemotherapy.. PubMed. 87(9). 3607–14. 219 indexed citations
9.
Young, John C., et al.. (1989). Exercise intensity and glucose tolerance in trained and nontrained subjects. Journal of Applied Physiology. 67(1). 39–43. 51 indexed citations
10.
Ribeiro, Jorge P., et al.. (1986). Effect of different incremental exercise protocols on the determination of lactate and ventilatory thresholds.. PubMed. 19(1). 109–17. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026